Compare TENX & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TENX | HFBL |
|---|---|---|
| Founded | 1967 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.1M | 73.1M |
| IPO Year | 2001 | 2010 |
| Metric | TENX | HFBL |
|---|---|---|
| Price | $1.72 | $20.06 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $9.63 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 3.5K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | N/A | ★ 60.32 |
| EPS | N/A | ★ 2.02 |
| Revenue | N/A | ★ $1,694,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.16 |
| Revenue Growth | N/A | ★ 30.01 |
| 52 Week Low | $1.31 | $14.47 |
| 52 Week High | $19.40 | $28.00 |
| Indicator | TENX | HFBL |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 27.17 |
| Support Level | $1.34 | $19.95 |
| Resistance Level | $2.00 | $23.87 |
| Average True Range (ATR) | 0.12 | 0.75 |
| MACD | 0.09 | -0.55 |
| Stochastic Oscillator | 70.91 | 3.55 |
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Home Federal Bancorp Inc of louisiana operates as a bank holding company. Through its subsidiary, a federally chartered stock savings bank, it provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial, and multi-family segments. The company also invests in securities held-to-maturity and securities available for sale.